Anaplasma marginale outer membrane protein vaccine candidates are conserved in North American and South African strains
Article in Ticks and Tick-borne Diseases (April 2020)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge
Article in PLOS ONE (February 2020)
VirB10 vaccination for protection against Anaplasma phagocytophilum
Article in BMC Microbiology (December 2018)